Group One Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,146
| Closed | -$32.9M | – | 8059 |
|
|
2024
Q4 | $30.9M | Sell |
100,146
-23,279
| -19% | -$6.55M | 0.07% | 243 |
|
|
2024
Q3 | $26.2M | Buy |
123,425
+47,026
| +62% | +$12M | 0.07% | 214 |
|
|
2024
Q2 | $21.4M | Buy |
76,399
+33,228
| +77% | +$7.91M | 0.08% | 183 |
|
|
2024
Q1 | $11.5M | Sell |
43,171
-148,760
| -78% | -$35.1M | 0.04% | 381 |
|
|
2023
Q4 | $44.4M | Buy |
191,931
+116,243
| +154% | +$20.3M | 0.12% | 113 |
|
|
2023
Q3 | $11.1M | Buy |
75,688
+73,004
| +2,720% | +$13.7M | 0.04% | 474 |
|
|
2023
Q2 | $620K | Buy |
+2,684
| New | +$727K | ﹤0.01% | 2800 |
|
|
2022
Q4 | – | Sell |
-16,534
| Closed | -$1.62M | – | 7751 |
|
|
2022
Q3 | $1.07M | Buy |
16,534
+8,975
| +119% | +$624K | ﹤0.01% | 2512 |
|
|
2022
Q2 | $541K | Buy |
+7,559
| New | +$556K | ﹤0.01% | 3348 |
|
|
2021
Q4 | – | Sell |
-1,233
| Closed | -$101K | – | 8585 |
|
|
2021
Q3 | $98K | Sell |
1,233
-100
| -8% | -$8.64K | ﹤0.01% | 5933 |
|
|
2021
Q2 | $130K | Buy |
1,333
+400
| +43% | +$47.4K | ﹤0.01% | 5695 |
|
|
2021
Q1 | $109K | Sell |
933
-2,332
| -71% | -$272K | ﹤0.01% | 5579 |
|
|
2020
Q4 | $363K | Sell |
3,265
-372
| -10% | -$45.5K | ﹤0.01% | 3557 |
|
|
2020
Q3 | $432K | Buy |
3,637
+3,500
| +2,555% | +$380K | ﹤0.01% | 2974 |
|
|
2020
Q2 | $16K | Buy |
+137
| New | +$13.5K | ﹤0.01% | 4923 |
|
|
2019
Q4 | – | Sell |
-1,666
| Closed | -$144K | – | 5412 |
|
|
2019
Q3 | $144K | Buy |
1,666
+900
| +117% | +$84.4K | ﹤0.01% | 3308 |
|
|
2019
Q2 | $80K | Buy |
766
+759
| +10,843% | +$81.3K | ﹤0.01% | 3516 |
|
|
2019
Q1 | $1K | Buy |
+7
| New | +$870 | ﹤0.01% | 4663 |
|
|
2016
Q4 | – | Sell |
-1,824
| Closed | -$23K | – | 4652 |
|
|
2016
Q3 | $23K | Sell |
1,824
-239
| -12% | -$2.32K | ﹤0.01% | 3731 |
|
|
2016
Q2 | $19K | Sell |
2,063
-319
| -13% | -$3.83K | ﹤0.01% | 3817 |
|
|
2016
Q1 | $20K | Sell |
2,382
-2,972
| -56% | -$24.8K | ﹤0.01% | 3742 |
|
|
2015
Q4 | $66K | Sell |
5,354
-1,495
| -22% | -$41K | ﹤0.01% | 3256 |
|
|
2015
Q3 | $417K | Sell |
6,849
-93
| -1% | -$6.71K | 0.01% | 1922 |
|
|
2015
Q2 | $542K | Buy |
6,942
+3,601
| +108% | +$302K | 0.01% | 1707 |
|
|
2015
Q1 | $227K | Buy |
3,341
+2,115
| +173% | +$181K | ﹤0.01% | 2275 |
|
|
2014
Q4 | $114K | Sell |
1,226
-1,319
| -52% | -$136K | ﹤0.01% | 2744 |
|
|
2014
Q3 | $268K | Buy |
+2,545
| New | +$354K | ﹤0.01% | 2142 |
|
|
2014
Q2 | – | Sell |
-1,000
| Closed | -$146K | – | 5356 |
|
|
2014
Q1 | $151K | Sell |
1,000
-2,246
| -69% | -$442K | ﹤0.01% | 2683 |
|
|
2013
Q4 | $595K | Buy |
+3,246
| New | +$594K | 0.01% | 1535 |
|
|
2013
Q3 | – | Sell |
-252
| Closed | -$53.6K | – | 5436 |
|
|
2013
Q2 | $44K | Buy |
+252
| New | +$65.7K | ﹤0.01% | 3526 |
|
Other funds holding MDGL
BBA
RI
JT
ACA
PC
Group One Trading's MDGL Position: Q1 2025 in Review
Group One Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2025, closing a stake of 100,146 shares — an estimated $32.9M sold.
Group One Trading first reported a position in MDGL in Q2 2013 and held it in 30 quarters. The position peaked at $44.4M in Q4 2023. 321 funds tracked by Wall St. Rank hold MDGL as of Q1 2025.
- Group One Trading reported no remaining Madrigal Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 100,146 Madrigal Pharmaceuticals shares in Q1 2025, an estimated $32.9M.
- Group One Trading first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Group One Trading's Madrigal Pharmaceuticals position peaked at $44.4M in Q4 2023.
- 321 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.